Welcome to the international HTA database

Showing [18637 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2004	New Zealand Health Technology Assessment (NZHTA)	What is the evidence for the effectiveness of specialist geriatric services in acute, post-acute and sub-acute settings? A critical appraisal of the literature
2015	NIHR Health Services and Delivery Research programme	What is the evidence for the effectiveness, appropriateness and feasibility of group clinics for patients with chronic conditions?
2005	New Zealand Health Technology Assessment (NZHTA)	What is the evidence for the safety and effectiveness of surgical and non-surgical interventions for patients with morbid obesity?
2015	NIHR Health Services and Delivery Research programme	What is the evidence on interventions to manage referral from primary to specialist non-emergency care? A systematic review and logic model synthesis
2004	New Zealand Health Technology Assessment (NZHTA)	What is the evidence on the safety and effectiveness of the reuse of medical devices labelled as single-use only?
2012	Scottish Health Technologies Group (SHTG)	What is the impact of using thresholds (both for referral and surgery) for first-eye cataract surgery on the delivery of the cataract service and the resources associated with it?
2000	Centre for Clinical Effectiveness (CCE)	What is the incidence of temporary epicardial pacemakers requiring troubleshooting?
2000	Centre for Clinical Effectiveness (CCE)	What is the most appropriate route of delivery for the preterm breech infant?
2000	Centre for Clinical Effectiveness (CCE)	What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD?
2000	Centre for Clinical Effectiveness (CCE)	What is the optimal positioning for patients with drug induced or non drug induced partial or total paralysis in intensive care unit?
2000	Centre for Clinical Effectiveness (CCE)	What is the optimum method for ensuring correct placement of nasogastric tubes?
2000	Centre for Clinical Effectiveness (CCE)	What is the prevalence of social skill, speech and language deficits in adolescents with significant psychiatric mental health problems?
2003	New Zealand Health Technology Assessment (NZHTA)	What is the prognostic value of calcium scoring in screening asymptomatic populations for cardiovascular disease? Evidence Tables
2012	Scottish Health Technologies Group (SHTG)	What is the published evidence of an association between hospital volume and operative mortality for surgical repair (open and endovascular) of unruptured and ruptured abdominal aortic aneurysms?
2012	Scottish Health Technologies Group (SHTG)	What is the published evidence of an association between hospital volume and outcome in elective carotid endarterectomy surgery?
2012	Scottish Health Technologies Group (SHTG)	What is the relative clinical effectiveness, cost effectiveness and safety of different bariatric surgery techniques (gastric bypass, gastric banding and sleeve gastrectomy)?
2002	New Zealand Health Technology Assessment (NZHTA)	What is the relative efficacy of different suicide assessment tools regardless of the restrictions on who can administer these? Evidence Tables
2001	Centre for Clinical Effectiveness (CCE)	What is the role of aminocaproic acid in the management of cerebral bleed post-thrombolytic therapy?
2000	Centre for Clinical Effectiveness (CCE)	What is the role of computer assisted decisions support systems (CADSS) in the continuing education of medical practitioners?
2001	Centre for Clinical Effectiveness (CCE)	What is the role of mood stablisers in the management of bipolar mood disorder in pregnancy?
2002	New Zealand Health Technology Assessment (NZHTA)	What is the safety of 'pepper spray' use by law enforcement or mental health service staff?
2001	Centre for Clinical Effectiveness (CCE)	What is the safety of open (Hasson) technique versus closed (blind Veress needle) technique for laparoscopy?
2013	Scottish Health Technologies Group (SHTG)	What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2001	Centre for Clinical Effectiveness (CCE)	What is the sensitivity and specificity of ultrasonography in the diagnosis of calf vein thrombosis?
2003	New Zealand Health Technology Assessment (NZHTA)	What is the value of a family history of premature cardiovascular disease in predicting increased cardiovascular risk? Evidence Tables
2012	NIHR Health Technology Assessment programme	What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature
2002	NIHR Health Technology Assessment programme	What is the value to society of a QALY: an investigation among the public in England and Wales
2002	NIHR Health Technology Assessment programme	What is the value to society of a QALY? A proposal to write a protocol
2002	New Zealand Health Technology Assessment (NZHTA)	What kind of follow-up is needed to reduce the risk of repeated suicide attempts/suicide? Evidence Tables
1999	NIHR Health Technology Assessment programme	What role for statins? A review and economic model
2018	NIHR Health Technology Assessment programme	What works to Increase attendance for Diabetic Retinopathy screening? An Evidence sYnthEsiS (WIDeR-EyeS)
2018	NIHR Health Technology Assessment programme	What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis
2004	NIHR Health Technology Assessment programme	What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
1997	NIHR Health Technology Assessment programme	When and how to assess fast-changing technologies: A comparative study of medical applications of four generic technologies
2002	Israel Center for Technology Assessment in Health Care (ICTAHC)	When is an epidemic an epidemic?
2002	NIHR Health Technology Assessment programme	Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial
2016	NIHR Health Technology Assessment programme	Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis
1995	University of York	Which way forward for the care of critically ill children?
2000	Norwegian Knowledge Centre for the Health Services (NOKC)	Whiplash injury - diagnosis and evaluation
2005	Adelaide Health Technology Assessment (AHTA)	White blood cell count testing to predict coronary artery disease in the general population
2009	Agency for Healthcare Research and Quality (AHRQ)	White paper: potential conflict of interest in the production of drug compendia
2012	HAYES, Inc.	Whole body vibration for the promotion of bone growth in postmenopausal women
2012	HAYES, Inc.	Whole breast irradiation for breast cancer using three-dimensional conformal radiation therapy or intensity-modulated radiation therapy
2013	HAYES, Inc.	Whole exome sequencing for cancer indications
2013	HAYES, Inc.	Whole exome sequencing for noncancer indications
2003	Institute for Clinical Systems Improvement (ICSI)	Whole-body computed tomography as a screening test
2012	HAYES, Inc.	Whole-body hyperthermia for cancer
2019	NIHR Health Technology Assessment programme	Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2004	Adelaide Health Technology Assessment (AHTA)	Whole-body MRI for the detection of metastases in patients with known malignant tumours
2003	Israel Center for Technology Assessment in Health Care (ICTAHC)	Why viral (SARS, Ebola and AIDS) epidemics now?
2016	Technology Assessment at SickKids (TASK)	Will the growth spurt continue? Trends in child health. Economic evaluation: 1980 to 2013
2008	HAYES, Inc.	Wingspan stent system with Gateway PTA balloon catheter (Boston Scientific Corp.) for intracranial atherosclerotic disease (ICAD)
2003	Blue Cross Blue Shield Association (BCBS)	Wireless capsule endoscopy
2003	HAYES, Inc.	Wireless capsule endoscopy
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Wireless capsule endoscopy
2005	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Wireless capsule endoscopy for bowel examination - study results
2003	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Wireless capsule endoscopy for bowel examination - systematic review, expert panel, primary research
2004	National Institute for Clinical Excellence (NICE)	Wireless capsule endoscopy for investigation of the small bowel
2003	Blue Cross Blue Shield Association (BCBS)	Wireless capsule endoscopy for small-bowel diseases other than obscure GI bleeding
2008	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Wireless capsule endoscopy in the diagnosis of small bowel disease
2003	Medical Advisory Secretariat (MAS)	Wireless capsule endoscopy: an evidence-based analysis
2017	HAYES, Inc.	Wireless capsule systems for diagnosis of gastroparesis and monitoring of gastrointestinal motility
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Wireless Cardiac Stimulation System for chronic heart failure
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Wireless device use and patient monitoring equipment in any healthcare delivery setting: a review of safety and guidelines
2008	HAYES, Inc.	Wireless esophageal ph monitoring
2004	HAYES, Inc.	Wireless esophageal pH monitoring
2012	Blue Cross Blue Shield Association (BCBS)	Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation
2013	Agency for Healthcare Research and Quality (AHRQ)	Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review
2016	HAYES, Inc.	Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
2015	HAYES, Inc.	Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
1995	Health Council of the Netherlands Gezondheidsraad (GR)	Women and children with HIV-infection or AIDS
1999	University of York	Women and secure psychiatric services: a literature review
2016	Health Quality Ontario (HQO)	Women's experiences of inaccurate breast cancer screening results: a systematic review and qualitative meta-synthesis
2003	Danish Institute for Health Services Research (DSI)	Work flow analysis in the County of Copenhagen - experiences and results from four work flow analysis'. DSI rapport
1999	Health Council of the Netherlands Gezondheidsraad (GR)	Work programme 1999
2007	National Institute for Health and Clinical Excellence (NICE)	Workplace health promotion: how to help employees to stop smoking
2005	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	Wound team: organization of treatment to patients with problem wounds - accelerated assessment
2004	Agency for Healthcare Research and Quality (AHRQ)	Wound-healing technologies: low-level laser and vacuum-assisted closure
2012	NIHR Horizon Scanning Centre (NIHR HSC)	WOUNDCHEK™ Protease status point of care test for chronic wounds
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Wrist sphygmomanometry versus upper arm sphygmomanometry: clinical effectiveness and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	X Collar versus conventional cervical collar
2007	HAYES, Inc.	X Stop interspinous process decompression system (Kyphon Inc.) for lumbar spinal stenosis
2010	HAYES, Inc.	X Stop Interspinous Process Decompression System (Medtronic Spine LLC) for lumbar spinal stenosis
2012	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2014	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	X-ray series for foot and ankle injuries: clinical evidence, cost-effectiveness, and guidelines
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Xaliproden (Xalprila) for Alzheimer's disease: horizon scanning technology briefing
2015	NIHR Horizon Scanning Centre (NIHR HSC)	XEN Gel Stent for glaucoma treatment
2014	HAYES, Inc.	Xenex PX ultraviolet light disinfection system (Xenex Disinfection Services LLC) for prevention of hospital-acquired infection
2016	HAYES, Inc.	Xenex PX Ultraviolet Light Disinfection System (Xenex Disinfection Services LLC) for prevention of hospital-acquired infection
1998	Health Council of the Netherlands Gezondheidsraad (GR)	Xenotransplantation
2001	Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS)	Xenotransplantation of cells
2001	The Swedish Council on Health Technology Assessment (SBU)	Xenotransplantation: renal transplantation example - early assessment briefs (ALERT)
1998	Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS)	Xenotransplantation: tested on heart and kidneys - short version
2016	NIHR Horizon Scanning Centre (NIHR HSC)	XG 102 for post-operative inflammation and pain following cataract surgery
2010	HAYES, Inc.	Xiaflex (collagenase clostridium histolyticum) (Auxilium Pharmaceuticals Inc.) for dupuytren contracture
2011	HAYES, Inc.	Xiaflex (collagenase Clostridium histolyticum) (Auxilium Pharmaceuticals Inc.) for dupuytren contracture
2001	NIHR Horizon Scanning Centre (NIHR HSC)	Xigris for severe sepsis - horizon scanning review
2004	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Ximelagatran for prevention and treatment of venous thromboembolism